Biopharmaceutical Innovation, Clinical Development & Therapeutic Modalities
Covers the evolution of biopharmaceutical R&D including advanced therapeutic modalities such as antibody-drug conjugates, cell and gene therapies, AI-driven drug discovery, and precision diagnostics. Encompasses clinical milestones, regulatory approvals, pipeline shifts between therapeutic areas like obesity and oncology, and the intersection of clinical innovation with healthcare economics and market dynamics.
Market dynamics shift as antibody conjugates become the baseline while artificial intelligence compresses discovery timelines and pricing pressures intensify globally.
